Faculty

Back to Index
John Richard Daniels, MD
Associate Professor of Medicine
Medicine
NOR 3450 Health Sciences Campus Los Angeles
+1 323 865 3901

Overview

Dr. Daniels, a native of Detroit, MI, holds nearly a dozen United States patents for his various medical inventions. An Associate Professor in both the departments of Radiology and Oncology, Dr. Daniels’ contributions to the Keck School of Medicine have been profound.

He‘s currently the Director of Endocare and a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Daniels has authored over 100 peer reviewed articles, book chapter and abstracts for influential medical journals. A graduate of Stanford University’s School of Medicine, Dr. Daniels has been a faculty member at the Keck School of Medicine since 1979.

Publications

Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol. 2011 Feb; 196(2):W220. View in: PubMed

Subselective intra-arterial chemotherapy infusion in the treatment of hepatocellular carcinoma. Semin Oncol. 2010 Apr; 37(2):83-8. View in: PubMed

Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):654-8. View in: PubMed

The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):43-7. View in: PubMed

Is cryosurgical ablation appropriate for treating hepatocellular cancer? Arch Surg. Is cryosurgical ablation appropriate for treating hepatocellular cancer? Arch Surg. 1997 Jun; 132(6):599-603; discussion 603-4. View in: PubMed

Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics. J Vasc Interv Radiol. 1994 Mar-Apr; 5(2):367-71. View in: PubMed

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol. 1991 Mar; 145(3):459-64; discussion 464-7. View in: PubMed

Intraarterial administration of lidocaine for analgesia in hepatic chemoembolization. J Vasc Interv Radiol. 1990 Nov; 1(1):81-5. View in: PubMed

Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer. Semin Urol. 1990 Nov; 8(4):279-84. View in: PubMed

Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney. Cancer Res. 1988 May 1; 48(9):2446-50. View in: PubMed

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. Cancer Res. 1988 Jan 15; 48(2):459-61. View in: PubMed

Transpancreatic catheterization of the right hepatic artery for chemoembolization using a new infusion system. Cathet Cardiovasc Diagn. 1988; 14(2):115-7. View in: PubMed

Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors. J Urol. 1987 Dec; 138(6):1397-401. View in: PubMed

Powered bySC CTSI